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See Article, pages 1143–1150The mucosal immune compartment of the gut functions as a bar-
rier for microbes and other extrinsic agents that might poten-
tially harm the host [1]. Due to its anatomical position at the
conﬂuence of portal and arterial blood, the liver functions as a
second barrier for gut-derived pathogens and microbial products
[2]. It is believed that this close functional link between gut and
liver could explain associations between inﬂammatory diseases
of gut and liver [1].
The most striking example is primary sclerosing cholangitis
(PSC) that is marked by portal liver inﬂammation and bile duct
obstruction; more than 80% of these patients suffer from ulcera-
tive colitis as a comorbidity [1]. One explanation for this patho-
genic link could be aberrant homing of mucosal lymphocytes to
the liver [1]. Indeed, gut-primed T cells were detected in livers
of PSC patients [3] and, in a recent murine study, gut-activated
CD8 T cells were found to induce antigen-speciﬁc cholangitis
[4]. Conversely, there is evidence that T cells primed in the liver
might inﬂuence mucosal immune responses in the gut, as CD4 T
cells primed by liver sinusoidal endothelial cells (LSECs) have
been shown to acquire a gut-homing phenotype [5]. The patho-
genic signiﬁcance and the rules of the proposed mutual T cell
trafﬁc along the gut-liver axis are thus far not clear.
The present study by Eickmeier et al. in this issue of the Jour-
nal of Hepatology provides a systematic analysis of the distinct
migration and activation patterns of CD8 T cells that were either
primed in the gut or in the liver. By adoptive transfer of naïve
ovalbumin (OVA)-speciﬁc OT-I cells to transgenic mice displaying
gut- or liver-restricted expression of OVA, they generated gut- or
liver-primed CD8 T cells in vivo. The differential migration behav-
iour of gut- or liver-activated OT-I T cells was then investigated in
secondary recipients. Conﬁrming previous reports that priming in
the gut-associated lymphoid tissue (GALT) confers gut tropism to
lymphocytes [6], the authors found that gut-activated CD8 T cells
preferentially accumulated in the small intestine, rather than in
lymphoid tissues. Moreover, gut-activated OT-I T cells were also
found to migrate to the livers of recipient mice, as has been
already recently reported by the same group [4]. Of note,Journal of Hepatology 20
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mice further increased hepatic accumulation of gut-activated
CD8 T cells, homing to the liver was observed irrespective of
hepatic antigen-presentation. These ﬁndings indicate that liver
inﬁltration by gut-primed CD8 T cells seems to occur by way of
antigen-independent bystander hepatitis. However, the induction
of liver pathology was only observed in mice featuring hepatic
OVA-expression [4]. Apart from the observed liver tropism of
gut-activated CD8 T cells, the present study showed that liver-
primed CD8 T cells did not accumulate in the gut, suggesting that
liver-activated CD8 T cells are not involved in intestinal immune
responses.
To further explore the different imprints of gut and liver on
activation and migration of CD8 T cells, Eickmeier et al. per-
formed transcriptome analysis of gut- or liver-activated CD8 T
cells that were isolated from mesenteric lymph nodes or from
the liver after in vivo priming. In line with previous reports that
intestinal activation by CD103+ dendritic cells (DCs) confers gut
tropism to T cells [6], gut-activated, but not liver-activated or
naïve OT-I T cells displayed signiﬁcant co-expression of the gut-
homing markers CCR9 and a4b7, explaining the observed exclu-
sion of liver-primed CD8 T cells from the gut. However, in the
present study, hepatic antigen expression was mainly conﬁned
to hepatocytes and it remains to be seen whether priming by
other liver antigen presenting cell types might result in diverse
migratory behaviors. Although stellate cells and liver dendritic
cells were not able to induce CCR9 and a4b7 expression in CD8
T cells [3], it is conceivable that LSECs might be able to induce
such phenotype in CD8 T cells, as this was recently shown for
LSEC-primed CD4 T cells [5].
In the present study, gut- or liver-speciﬁc priming of CD8 T
cells occurred under non-inﬂammatory conditions, however, it
is most likely that an inﬂammatory context during priming
greatly inﬂuences the activation status and migration behavior
of CD8 T cells. Indeed, proinﬂammatory cytokines or microbial
products greatly increase production of T cell-attracting chemo-
kines and adhesion molecules [1], and promote maturation of
antigen-presenting cells [7]. In fact, hepatic upregulation of
CCL25 and MAdCAM, the respective binding partners for CCR9
and a4b7, has been observed in inﬂamed livers of PSC patients
[8]. In contrast, Eickmeier et al. did not observe hepatic expres-
sion of CCL25 and MAdCAM here, presumably due to the absence14 vol. 60 j 1110–1111
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of hepatic inﬂammation in their model. The question then is how
hepatic accumulation of gut-derived CD8 T cells occurred, not-
withstanding the absence of CCL25 and MAdCAM? One might
speculate that additional chemokine ligands such as CXCR3
ligands or integrins that allow binding to ICAM-1 and VCAM-1
[9] could be responsible for hepatic transendothelial migration
of gut-primed CD8 T cells under non-inﬂammatory conditions.
Nonetheless, further studies are needed to investigate how
inﬂammation at the priming site or in the target organ can inﬂu-
ence enterohepatic T cell activation and migration.
Conﬁrming their previous ﬁndings, Eickmeier et al. found that
gut-primed CD8 T cells display an activated phenotype. Liver-
primed CD8 T cells, however, showed a distinct phenotype with
markers of activated (CD44), naïve (CD62L), and central memory
cells (Ly6C). Interestingly, liver-activated T cells also expressed
Neuropilin-1 (Nrp-1). Note that a similar Nrp-1+ central-memory
like phenotype was recently found to be induced in naïve CD8 T
cells by liver sinusoidal endothelial cells (LSECs) [10]. These LSEC-
primed memory CD8 T cells can acquire effector function upon
antigen-speciﬁc re-stimulation in an inﬂammatory environment
[10]. Thus, although intrahepatic priming of CD8 T cells usually
results in tolerance [11] or an apoptosis-prone phenotype [12],
it is conceivable that LSEC-primed memory CD8 T cells might
re-encounter their cognate antigen in the gut and might thereby
contribute to mucosal immunity. The recent ﬁnding that LSECs
can confer a gut-homing phenotype to CD4 T cells [4] seems to
support this notion. It remains to be seen, whether autoimmune
liver diseases might result from inﬂammatory reactivation in the
gut of long-lived memory cells recognizing antigens present in
the liver. Indeed, a study by the Adams group, showing a mem-
ory-phenotype of CCR9+ T cells in PSC livers, seems to point in
this direction [13].
In addition to the analysis of enterohepatic CD8 T cell migra-
tion, future studies should also address the migration patterns of
CD4 T cells. Gut-primed CD4 T cells can induce hepatitis in IL10-
deﬁcient mice after Trichinella spiralis infection [14]. Moreover,
liver inﬁltration with Th17 cells has been found in patients
suffering from diverse autoimmune liver diseases [15]. Since
the gut is a prime site of Th17 induction in response to bacterial
stimulation [16], it seems likely that gut-derived Th17 cells might
contribute to hepatic inﬂammation.Financial support
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